The Use of Succinylcholine in Brugada Syndrome: A Case Report and Discussion of Literature-Reference-Cited by-同舟云学术

The Use of Succinylcholine in Brugada Syndrome: A Case Report and Discussion of Literature

Published:2019-10-27 Issue: Volume:2019 Page:1-3
ISSN:2090-6382
Container-title:Case Reports in Anesthesiology
language:en
Short-container-title:Case Reports in Anesthesiology

Author:

de Wolf Marcus M.¹^ORCID,Rus Nellie M.¹,Beljaars Guus H.²³,Tan Hanno L.⁴

Affiliation:

1. Psychiatrist, GGZ Delfland, Centre for Mental Health, Delft, Netherlands

2. Anesthesiologist, GGZ Delfland, Center for Mental Health, Delft, Netherlands

3. Albert Schweitzer Hospital, Dordrecht, Netherlands

4. Cardiologist, Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Abstract

We describe a patient with a major depression and a newly discovered Brugada syndrome, who was successfully treated with 35 electroconvulsive therapy sessions using succinylcholine as muscle relaxant. We discuss the use of succinylcholine in patients with Brugada syndrome.

Publisher

Hindawi Limited

Subject

Anesthesiology and Pain Medicine

Link

http://downloads.hindawi.com/journals/cria/2019/5182672.pdf

Reference15 articles.

1. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome

2. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes

3. Proposed Diagnostic Criteria for the Brugada Syndrome

4. Brugada syndrome as a potential cardiac risk factor during electroconvulsive therapy (ECT)

5. General anesthesia for electroconvulsive therapy with Brugada electrocardiograph pattern